138 related articles for article (PubMed ID: 12025886)
1. Effect of vinorelbine monotherapy in taxane-treated patients with advanced non-small-cell lung cancer.
Miyata J; Sano T; Bando H
Med Oncol; 2002; 19(1):11-4. PubMed ID: 12025886
[TBL] [Abstract][Full Text] [Related]
2. [A trial with single-agent vinorelbine in taxane-resistant non-small cell lung cancer].
Miyata J; Sano T; Bando H
Gan To Kagaku Ryoho; 2001 Feb; 28(2):239-42. PubMed ID: 11242654
[TBL] [Abstract][Full Text] [Related]
3. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
Kanazawa J; Morimoto M; Ohmori K
Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
[TBL] [Abstract][Full Text] [Related]
4. New drugs in non-small cell lung cancer. An overview.
Giaccone G
Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Fossella FV; DeVore R; Kerr RN; Crawford J; Natale RR; Dunphy F; Kalman L; Miller V; Lee JS; Moore M; Gandara D; Karp D; Vokes E; Kris M; Kim Y; Gamza F; Hammershaimb L
J Clin Oncol; 2000 Jun; 18(12):2354-62. PubMed ID: 10856094
[TBL] [Abstract][Full Text] [Related]
6. Salvage therapy with vinorelbine in advanced non-small-cell lung cancer: a retrospective review of the Fox Chase Cancer Center experience and a review of the literature.
Devlin JG; Langer CJ
Clin Lung Cancer; 2007 Mar; 8(5):319-26. PubMed ID: 17562231
[TBL] [Abstract][Full Text] [Related]
7. Vinorelbine for non-small cell lung cancer.
Piccirillo MC; Daniele G; Di Maio M; Bryce J; De Feo G; Del Giudice A; Perrone F; Morabito A
Expert Opin Drug Saf; 2010 May; 9(3):493-510. PubMed ID: 20350282
[TBL] [Abstract][Full Text] [Related]
8. Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.
Goss GD; Logan DM; Newman TE; Evans WK
Cancer Prev Control; 1997; 1(1):28-38. PubMed ID: 9765724
[TBL] [Abstract][Full Text] [Related]
9. Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study.
Makrantonakis P; Ziotopoulos P; Agelidou A; Polyzos A; Ziras A; Chandrinos V; Vossos A; Kalykaki A; Androulakis N; Geroyianni A; Georgoulias V;
Lung Cancer; 2006 Jul; 53(1):85-90. PubMed ID: 16720058
[TBL] [Abstract][Full Text] [Related]
10. [Clinical trials of vnorelbine in breast cancer--its scientific usefulness and development history until regulatory approval].
Tominaga T
Gan To Kagaku Ryoho; 2006 Apr; 33(4):541-7. PubMed ID: 16612169
[TBL] [Abstract][Full Text] [Related]
11. [New cytostatics in the therapy of non-small cell bronchial carcinoma].
Serke M; Schönfeld N; Loddenkemper R
Pneumologie; 1998 Jun; 52(6):333-7. PubMed ID: 9715648
[No Abstract] [Full Text] [Related]
12. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
14. Single-agent vinorelbine in the treatment of non-small cell lung cancer.
Wozniak AJ
Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010
[TBL] [Abstract][Full Text] [Related]
15. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
16. A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.
Chen YM; Perng RP; Shih JF; Tsai CM; Whang-Peng J
Lung Cancer; 2007 Jun; 56(3):363-9. PubMed ID: 17306906
[TBL] [Abstract][Full Text] [Related]
17. Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer.
Jones SF; Burris HA
Ann Pharmacother; 1996 May; 30(5):501-6. PubMed ID: 8740332
[TBL] [Abstract][Full Text] [Related]
18. Mitomycin plus vinorelbine salvage chemotherapy in non-small cell lung cancer: a prospective study.
Berghmans T; Gourcerol D; Lafitte JJ; Kotsori K; Paesmans M; Scherpereel A; Leclercq N; Sculier JP;
Lung Cancer; 2008 Sep; 61(3):378-84. PubMed ID: 18313792
[TBL] [Abstract][Full Text] [Related]
19. Single agents in the second-line treatment of non-small cell lung cancer.
Belani CP
Semin Oncol; 1998 Jun; 25(3 Suppl 8):10-4. PubMed ID: 9704670
[TBL] [Abstract][Full Text] [Related]
20. Management of elderly patients with lung cancer.
Ranson MR; White S; Thatcher N
Curr Oncol Rep; 2000 Jan; 2(1):90-5. PubMed ID: 11122829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
